Roble, Belko & Company, Inc Elanco Animal Health Inc Transaction History
Roble, Belko & Company, Inc
- $634 Million
- Q3 2024
Shares
4 transactions
Others Institutions Holding ELAN
# of Institutions
437Shares Held
473MCall Options Held
4.62MPut Options Held
753K-
Dodge & Cox San Francisco, CA83.3MShares$990 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA52.6MShares$625 Million0.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.9MShares$581 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$277 Million0.01% of portfolio
-
Black Creek Investment Management Inc. Toronto, A621.3MShares$253 Million11.09% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.63B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...